www.fdanews.com/articles/197992-diasorin-earns-ce-mark-for-flu-assay-to-run-with-covid-19-test
DiaSorin Earns CE Mark for Flu Assay to Run with COVID-19 Test
July 9, 2020
DiaSorin has earned a CE Mark for its Simplexa Flu A/B and respiratory syncytial virus (RSV) Direct Gen II assay kit.
The flu test can be run on its own or alongside the company’s Simplexa COVID-19 Direct kit. The assay runs on DiaSorin’s Liaison MDX system.
Viral infections caused by Flu A, Flu B, RSV and SARS-CoV-2 have similar clinical presentations, but the treatment options are different, the company noted.